Regular aspirin use may not benefit patients with AMD

MedPage Today (12/1, Bankhead) reported that “theoretical benefits of regular aspirin use in age-related macular degeneration (AMD) failed to pan out in a review of data from a large cohort study of female health professionals.” In a study involving “39,876 healthy women followed for an average of 10 years,” researchers from the Harvard School of Public Health found that “participants randomized to take low-dose aspirin every other day had a nonsignificant 18% reduction in the risk of AMD, compared with the placebo group after 10 years of follow-up.” In fact, “combining all cases of AMD with or without vision impairment resulted in 302 cases in the aspirin group versus 291 in the placebo group.” The research is published in the Dec. issue of the journal Ophthalmology.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: